Abstractobjective To investigate risk factors associated with the acquisition of antibodies against Plasmodium vivax Duffy binding protein (PvDBP) -a leading malaria vaccine candidate -in a well-consolidated agricultural settlement of the Brazilian Amazon Region and to determine the sequence diversity of the PvDBP ligand domain (DBP II ) within the local malaria parasite population.methods Demographic, epidemiological and clinical data were collected from 541 volunteers using a structured questionnaire. Malaria parasites were detected by conventional microscopy and PCR, and blood collection was used for antibody assays and molecular characterisation of DBP II .results The frequency of malaria infection was 7% (6% for P. vivax and 1% for P. falciparum), with malaria cases clustered near mosquito breeding sites. Nearly 50% of settlers had anti-PvDBP IgG antibodies, as detected by enzyme-linked immunosorbent assay (ELISA) with subject's age being the only strong predictor of seropositivity to PvDBP. Unexpectedly, low levels of DBP II diversity were found within the local malaria parasites, suggesting the existence of low gene flow between P. vivax populations, probably due to the relative isolation of the studied settlement.conclusion The recognition of PvDBP by a significant proportion of the community, associated with low levels of DBP II diversity among local P. vivax, reinforces the variety of malaria transmission patterns in communities from frontier settlements. Such studies should provide baseline information for antimalarial vaccines now in development.

Eighteen patients with acute Schistosoma mansoni infection were followed up for 2 years after treatment with praziquantel or oxamniquine. Cure rates, clinical features, abdominal ultrasonographic findings, and specific humoral responses were determined at 2-, 6-, and 24-month follow-ups. Fourteen patients (77.8%) were considered parasitologically cured. Levels of IgA antibody to soluble egg antigen (SEA) and IgM antibody to keyhole limpet hemocyanin (KLH) became negative or decreased to the cutoff level for chronic infection 2 months after treatment, while levels of IgG antibody to KLH declined between 12 and 24 months after treatment. Levels of IgM and IgG antibodies to saline worm adult protein as well as IgM and IgG antibodies to SEA remained positive during the follow-up period. Discrete lymph node enlargement and hepatomegaly were still present in six of the eight cured children 2 years after treatment, while complete regression was observed in adults. In our group of patients, in addition to presenting with more intense clinical manifestations, children were cured less often and had slower abatement of symptomatology after treatment than adults.

Seventy three children (6-15 years) and 75 adults (18-47 years) with active schistosomiasis mansoni were treated with oltipraz. All cases had at least 100 eggs per gram of feces as determined by the Kato-Katz technique. Children and adults were divided in two groups receiving respectively 25 or 30 mg/kg, as a single oral dose. Clinical examination, laboratories tests (haemogram, urinalysis, hepatic and kidney functions tests, glycemia, cholesterol, triglicerides, lipoprotein — HLD and LDL) and ECG were performed before, 3 or 7 days and 1 month after treatment. Parasitological control with 3 daily coprological examinations, was done on the 1st, 3rd j 6th month after drug administration. Giddiness, somnolence, headache, nausea, vomiting and abdominal distress were the most frequent side effects. Pain in the finger tips that need further investigations also occurred. No significant alteration in complementary tests were observed, whereas eosinophilia 1 month after treatment was detected, probably indicating worm death. The cure rate in children was 81.8% and 74.2% with 25 and 30 mg/kg respectively, and in adults 75.0% and 81.2% of the patients. No statistical significant difference was observed between cure rate and side effects at different dosages employed, neither between adults nor children. In all groups the percentage of egg reduction in feces in the non cured patients was higher than 96.0%. Further investigation with this new compound is necessary to accomplish the real value of oltipraz in the schistosomiasis chemotherapy.

O objetivo desse trabalho foi determinar a prevalência das parasitoses em escolares de Bambuí, através de exames coprológicos (direto e Kato-Katz) e reavaliar os criadouros de moluscos descritos no município. Dos 2.901 escolares examinados, 20,1% estavam parasitados, sendo que Giardia lamblia, Entamoeba coli, Ascaris lumbricoides e ancilostomídeos foram os parasitas mais freqüentes, com prevalências de 6,2%, 6,2%, 4,8% e 1,4%, respectivamente. Os ancilostomídeos foram significativamente mais freqüentes na zona rural e nos alunos com mais de 14 anos, enquanto a prevalência da E. coli foi maior na zona urbana e a G. lamblia mais freqüente na faixa etária de 0-6 anos. Somente três crianças eliminavam ovos de Schistosoma mansoni. O único hospedeiro intermediário encontrado foi a Biomphalaria glabrata e nenhuma delas estava eliminando cercárias de S. mansoni . Comparando-se estes dados a de levantamentos realizados anteriormente no município, observou-se uma queda na prevalência de todos os parasitas. Algumas hipóteses para tentar explicar esta queda são discutidas tais como: processo intenso de urbanização e a melhoria das condições sócio-sanitárias do município.

No abstract

The Plasmodium vivax Duffy binding protein (PvDBP) and its erythrocytic receptor, the Duffy antigen receptor for chemokines (DARC), are involved in the major P. vivax erythrocyte invasion pathway. An open cohort study to analyze DARC genotypes and their relationship to PvDBP immune responses was carried out in 620 volunteers in an agricultural settlement of the Brazilian Amazon. Three cross-sectional surveys were conducted at 6-month intervals, comprising 395, 410, and 407 subjects, respectively. The incidence rates of P. vivax infection was 2.32 malaria episodes per 100 person-months under survey (95% confidence interval [CI] of 1.92-2.80/100 person-month) and, of P. falciparum, 0.04 per 100 person-months (95% CI of 0.007–0.14/100 person-month). The distribution of DARC genotypes was consistent with the heterogeneous ethnic origins of the Amazon population, with a predominance of non-silent DARC alleles: FY*A > FY*B. The 12-month follow-up study demonstrated no association between DARC genotypes and total IgG antibodies as measured by ELISA targeting PvDBP (region II, DBPII or regions II–IV, DBPII-IV). The naturally acquired DBPII specific binding inhibitory antibodies (BIAbs) tended to be more frequent in heterozygous individuals carrying a DARC-silent allele (FY*BES). These results provide evidence that DARC polymorphisms may influence the naturally acquired inhibitory anti-Duffy binding protein II immunity.

A infecção pelo Helicobacter pylori (H. pylori) é uma das mais prevalentes entre os seres humanos. Estima-se que afete cerca de metade da população mundial, e no Brasil, a prevalência é de aproximadamente 60%. A H. pylori é uma bactéria que coloniza a mucosa estomacal causando distúrbios gástricos que podem evoluir para gastrites, úlceras, dispepsias e carcinomas. O presente estudo tem por objetivo abordar aspectos da infecção pelo H. pylori, seu diagnóstico laboratorial e tratamento. Para tal, trata-se de uma revisão da literatura com trabalhos selecionados em revistas indexadas nas bases de dados LILACS, MEDLINE/PubMed, PLoS e SciELO, sob os unitermos e suas combinações: H. pylori, epidemiologia, distúrbios gástricos, diagnóstico laboratorial, tratamento. A infecção pelo H. pylori apresenta importância epidemiológica e clínica e a transmissão se dá principalmente de pessoa a pessoa, sendo aceitas como formas de transmissão as vias oral-oral, fecal-oral e iatrogênica. Os métodos diagnósticos para detecção da bactéria podem ser baseados em testes realizados durante exame endoscópico (invasivos) e sem exame endoscópico (não invasivo). Essas metodologias, embora com certas limitações, têm permitido o diagnóstico da infecção com eficiência, rapidez e segurança. A erradicação não é simples e os esquemas terapêuticos necessitam associação de múltiplos agentes farmacológicos.

Summaryobjective To evaluate the clinical value of flow cytometry anti-live promastigate antibody (FC-ALPA), for diagnosing active cutaneous leishmaniasis. results In population 1, FC-ALPA-IgG performed better than the immunofluorescence assay regarding sensitivity, specificity and predictive values. Analysis of the results according to the likelihood ratios indicated that a percentage of positive fluorescent parasite £60 practically excludes the diagnosis of localized cutaneous leishmaniasis (likelihood ratio ¼ 0.07), whereas at >60% it reinforces diagnosis of the disease (likelihood ratio ¼ 7.0). Immunofluorescent assay is of little value (likelihood ratio ¼ 2.04).In population 1A, both tests performed worse, but FC-ALPA-IgG achieved better statistical indexes than immunofluorescent assay.conclusion The FC-ALPA-IgG is a valuable method for serological diagnosis of localized cutaneous leishmaniasis. FC-ALPA-IgG1/ALPA-IgG2 combined analysis is an additional serological tool for discriminating localized visceral leishmaniasis, Chagas disease and visceral leishmaniasis in areas where these infections co-exist.keywords localized cutaneous leishmaniasis, anti-live Leishmania (V.) braziliensis promastigotes, IgG antibodies, serodiagnosis, flow cytometry, performance indexes